RadNet, Inc. (RDNT) is a Healthcare company in the Diagnostics Research industry. It has a market capitalization of $5.82B, a trailing price-to-earnings ratio of 168.0 and a free-cash-flow yield of 1.5%. Over the most recent reported fiscal year, revenue grew 11.5% and free cash flow per share grew 89.3%.